#bestcli - Twitter Hashtag

6 months ago

In this #JACCINT analysis from #BESTCLI, use of #atherectomy during endovascular revascularization for #CLTI was not associated with improved outcomes, including MALE, major reintervention, above-ankle amputation, or all-cause death https://t.co/1SmT0dTdzO

JACCJournals's tweet photo. In this #JACCINT analysis from #BESTCLI, use of #atherectomy during endovascular revascularization for #CLTI was not associated with improved outcomes, including MALE, major reintervention, above-ankle amputation, or all-cause death https://t.co/1SmT0dTdzO https://t.co/wltt5nch6e

2

14

2

5

2K

Jianing Yue_Vas Surg in Shanghai @yuejianing

about 1 year ago

Together with the Münster Eluvia stent study, this #BESTCLI subanalysis also demonstrated that endo w/ drug devices can achieve comparable outcomes and has the potential to replace most above-the-knee bypasses. At the same time, it highlights that we still need distal and ultra-distal bypasses to address popliteal and BTK #CLTI cases where endo fall short.

Journal of Vascular Surgery @JVascSurg

about 1 year ago

Remember when DCB's safety was being questioned? Efficacy in reducing major reinvention and all-cause mortality in CLTI is being published now. Full article can be found here: https://t.co/JyPEzNhpeS

JVascSurg's tweet photo. Remember when DCB's safety was being questioned? Efficacy in reducing major reinvention and all-cause mortality in CLTI is being published now. Full article can be found here: https://t.co/JyPEzNhpeS https://t.co/Pf5cIqvN33

1

26

11

4

5K

1

14

1

2K

Jianing Yue_Vas Surg in Shanghai @yuejianing

over 1 year ago

Thank you, #BESTCLI team, to provide such a great session in #veith2024

0

11

1

0

691

Jianing Yue_Vas Surg in Shanghai @yuejianing

almost 2 years ago

#BESTCLI cohort I in the right, and cohort II in the left. Both fibulectomy. In-situ GSV vs ePTFE+DVP. Let's wait and see. #CLTIFighter #limbsalvage

yuejianing's tweet photo. #BESTCLI cohort I in the right, and cohort II in the left. Both fibulectomy. In-situ GSV vs ePTFE+DVP. Let's wait and see. #CLTIFighter #limbsalvage https://t.co/4RYuxmzHlY

2

32

5

1

7K

MIЯVΛƬ #IC ༄ ｡°

@mirvatalasnag

about 2 years ago

#BestCLI @nejm https://t.co/OxgL8swDCN Commentary: @CraigMWalkerMD 💉Primary outcome driven by endo failure 💉Technical failure: 1.7% vs 15.3% failure surgery vs endo (not aligned w previously published data) 💉MALE & all cause death 60% not aligned w contemporary data Only 7% had atherectomy & ? Alternate access 💉Exclusion after randomization ?

mirvatalasnag's tweet photo. #BestCLI @nejm

https://t.co/OxgL8swDCN

Commentary:
@CraigMWalkerMD

💉Primary outcome driven by endo failure
💉Technical failure: 1.7% vs 15.3% failure surgery vs endo (not aligned w previously published data)
💉MALE & all cause death 60% not aligned w contemporary data
Only 7% had atherectomy & ? Alternate access
💉Exclusion after randomization ?

0

2

0

1

459

CAMC Vascular Surgery Residency and Fellowship @CAMCVascularIAM

about 2 years ago

Two different pathologies, one surgical repair: open common femoral artery repair with fem-AT bypass with GSV for CLTI and non-healing wound. Expertly done by our chief resident Adrian Santini, MD and second-year Robert Cragon, MD! #bestCLI

CAMCVascularIAM's tweet photo. Two different pathologies, one surgical repair: open common femoral artery repair with fem-AT bypass with GSV for CLTI and non-healing wound. Expertly done by our chief resident Adrian Santini, MD and second-year Robert Cragon, MD! #bestCLI https://t.co/Py8aupYpT4

0

14

1

0

890

🇵🇰Zeeshanزیشان🍉🇮🇪 @Z__AC

about 2 years ago

No better feeling than finding single segment GSV all the way from SFJ to foot. Fem-DP bypass using in situ GSV with US guided micro incisions for liga clipping of tributaries! #BestCLI #AmputationSuck #VascTwitter @farkomd @JimGMelton @ahmedkayssi

Z__AC's tweet photo. No better feeling than finding single segment GSV all the way from SFJ to foot.
Fem-DP bypass using in situ GSV with US guided micro incisions for liga clipping of tributaries!
#BestCLI #AmputationSuck #VascTwitter
@farkomd @JimGMelton @ahmedkayssi https://t.co/BI1ZfEQdEx

10

34

2

0

3K

Andrue Lee @andruelee

over 2 years ago

Another bypass, another vein. #bestCLI

0

8

0

291

Jianing Yue_Vas Surg in Shanghai @yuejianing

over 2 years ago

A #BESTCLI cohort II pt. R5 ischemia after multiple endos for FP ISR, single per runoff, GSV unavailable, cardiomyopathy. So, easy mode in bypass surgery: HePTFE+DVP #CLTI #CLTIFighter

yuejianing's tweet photo. A #BESTCLI cohort II pt. R5 ischemia after multiple endos for FP ISR, single per runoff, GSV unavailable, cardiomyopathy. So, easy mode in bypass surgery: HePTFE+DVP #CLTI #CLTIFighter https://t.co/u9F61iSjkG

6

49

4

5K

Amandeep Juneja MD @AngioPod

over 2 years ago

My favorite #surgvasc insitu bypass 89 y.o female non healing wounds 7 months CTO sfa, p1p2 with p3 recon. Good vein- #bestcli @Kuldeep1926 @TedGiffordMD @jmills1955 @canuc_57 @farkomd @VascularSVS @FutureVascSurgn

AngioPod's tweet photo. My favorite #surgvasc insitu bypass
89 y.o female non healing wounds 7 months CTO sfa, p1p2 with p3 recon. Good vein- #bestcli @Kuldeep1926 @TedGiffordMD @jmills1955 @canuc_57 @farkomd @VascularSVS @FutureVascSurgn https://t.co/ecSKZfdQN9

5

18

2

1

2K

Andrue Lee @andruelee

over 2 years ago

#bestCLI

1

3

0

278

W. Michael Park, MD @docpark

over 2 years ago

This is the sound of victory #vascsurg #bestcli

3

48

3

2

5K

W. Michael Park, MD @docpark

over 2 years ago

In situ fem-AK pop bypass in preference to 25cm of stents through SFA CTO. #VASCSURG, #bestcli

5

54

2

5K

Vascupedia @Vascupedia_com

over 2 years ago

Most views ②⓪②③ 3rd Place 🥉| Incorporating the BEST-CLI trial into clinical practice: Where it Applies and Where we Need More Data | Episode 1 https://t.co/8ZeUTWURR6 @EricSecemskyMD @vascularIR @a_saratzis @_backtable #BESTCLI #RCT #education #Vascupedia #webinar

Vascupedia_com's tweet photo. Most views ②⓪②③
3rd Place 🥉| Incorporating the BEST-CLI trial into clinical practice:
Where it Applies and Where we Need More Data | Episode 1

https://t.co/8ZeUTWURR6

@EricSecemskyMD @vascularIR @a_saratzis

@_backtable
#BESTCLI #RCT #education #Vascupedia #webinar https://t.co/BL3JkWZ2lS

0

9

2

1

1K

Jianing Yue_Vas Surg in Shanghai @yuejianing

over 2 years ago

1 yr CT scan F/U after in-situ bypass for a 84y R5 ischemia pt. And the F/U ABI is 1.03. We are vascular surgeons, we provide effectiveness and durability. #CLI #BESTCLI

yuejianing's tweet photo. 1 yr CT scan F/U after in-situ bypass for a 84y R5 ischemia pt. And the F/U ABI is 1.03. We are vascular surgeons, we provide effectiveness and durability. #CLI #BESTCLI https://t.co/JH7HLW4DdM

1

64

7

1

5K

Daniel Delgadillo, MD @Delgadillo3D

almost 3 years ago

Patient with CLTI and good GSV now s/p Pop-PT bypass! Practicing evidence based medicine @UCIVascularSurg @Kabutey_MD @chauvascular @RMFujitaniMD @SamuelChenMD @IsabellaKuoMD #Vascular #Everyday #PAD #Bypass #BestCLI #MedEd #MedTwitter Bypass #14

Delgadillo3D's tweet photo. Patient with CLTI and good GSV now s/p Pop-PT bypass! Practicing evidence based medicine @UCIVascularSurg @Kabutey_MD @chauvascular @RMFujitaniMD @SamuelChenMD @IsabellaKuoMD

#Vascular #Everyday #PAD #Bypass #BestCLI #MedEd #MedTwitter
Bypass #14 https://t.co/aX6fCONkrQ

1

8

2

0

542

Dejah Judelson (she/her) @DejahJudelson

about 3 years ago · Worcester

Absolutely incredible editorial by @limbsalvagedr and @MichaelSConteMD comparing two pivotal #CLTI trials #BESTCLI and #BASIL2 @JVascSurg

David G. Armstrong follow @dgarmstrong.bsky.social @DGArmstrong

about 3 years ago

🍎🍊 Apples and oranges? Check out this informative comparison of BEST-CLI to BASIL-2! Find out more about the latest research in vascular surgery. #JVascSurg #UCSFVascular - DF Blog https://t.co/iBeX30kSb5